Orano Med Revenue
Biotechnology Research • 
Plano, Texas, United States • 201-500 Employees
Orano Med revenue & valuation
| Annual revenue | $17,500,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $55,900,000 |
| Total funding | No funding |
Key Contacts at Orano Med
Romuald-Alexis Lejard
Atlab Director
Rachel Morra
Business Development And Alliance Management Director
Gwenaelle Nourry
Orano Med Hr Director
Katherine Ruffner
Executive Director
Jean-René Basque
Global Clinical Program Scientific Director, Oranomed Theranostics
Nicolas Bozovic
Director Of Pharmaceutical Operations And Projects
Wegener Antje
Executive Director, Clinical Development
Vitaliy Gisin
Director Clinical Development / Senior Clinical Scientist
Carter Rose
Associate Director, Ms&T
Rachel Woloski
Sr. Director, Clinical Operstions
Company overview
| Headquarters | 700 Klein Road, Plano, TX 75074, US |
| Phone number | +14696380632 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Biotechnology, Pharmaceutical, Clinical Trial, Nuclear Medicine & Nuclear Industry |
| Founded | 2009 |
| Employees | 201-500 |
| Socials |
Orano Med Email Formats
Orano Med uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@oranomed.com), used 62.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@oranomed.com | 63.7% |
{first initial}.{last name} | j.doe@oranomed.com | 35% |
{last name}.{first initial} | doe.j@oranomed.com | 1.2% |
About Orano Med
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Orano Med has 114 employees across 11 departments.
Departments
Number of employees
Funding Data
Orano Med has never raised funding before.
Orano Med Tech Stack
Discover the technologies and tools that power Orano Med's digital infrastructure, from frameworks to analytics platforms.
CDN
Security
JavaScript libraries
Maps
Personalisation
JavaScript libraries
CMS
JavaScript libraries
Security
Web frameworks
Analytics
Saudi Arabia
Israel
United Arab Emirates
Australia
Frequently asked questions
4.8
40,000 users
